stockportfolio.pro
Stocks / SNN vs SOLV
SNN vs SOLV
Smith & Nephew plc and Solventum Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Smith & Nephew plc (SNN) | Solventum Corporation (SOLV) | |
|---|---|---|
| Market cap | $12.9B | $13.3B |
| Revenue (latest FY) | $6.16B | $8.32B |
| Net income (latest FY) | $625.00M | $1.56B |
| Revenue growth (5y CAGR) | 5.7% | 0.8% |
| Net margin | 10.1% | 18.7% |
| Return on equity | 11.8% | 30.8% |
| P/E ratio | 21.3 | 9.4 |
| Dividend yield | 2.5% | — |
| Profitable years (of last 10) | 4 | 4 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open SNN — free Open SOLV — freeFrequently asked questions
Which is bigger, SNN or SOLV?
Solventum Corporation is larger by market capitalization — $13.3B versus $12.9B.
Which grows faster, SNN or SOLV?
Over the last five fiscal years, Smith & Nephew plc grew revenue faster — 5.7%/yr versus 0.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.